Half of planned clinical sites will be activated this month; more than 20 patients have been pre-identified across participating centers Company to hold Type D meeting with FDA to discuss a potential ...

A three-year randomized controlled trial found that the benefits continued to grow after the program ended. SAN ANTONIO, TX / ACCESS Newswire / July 13, 2026 / A new study by researchers at Rice ...

Shape Memory Medical Inc., developer of a commercially available volume-expanding shape memory polymer for endovascular embolizatio ...

Safety and performance results from PATHFINDER 2, a registrational study of a multi-cancer early detection (MCED) test in an intended-use population. This is an ASCO Meeting Abstract from the 2026 ...

Targeted indoor residual spraying focuses insecticide applications on common resting surfaces of Aedes aegypti mosquitoes (an arboviral disease vector) in houses, such as exposed lower sections of ...

Dartmouth-linked study found strong academic gains among students using an AI tutor, but researchers say larger trials are ...

Background Double sequential defibrillation (DSD) is a promising treatment for patients with out-of-hospital cardiac arrest ...

Published today in Schizophrenia Bulletin, a first-of-its-kind randomized controlled trial (RCT) from researchers at the ...

Shape Memory Medical Inc., developer of the only commercially available volume‑expanding shape memory polymer for endovascular embolization, announced today that it has completed enrollment in the AAA ...